close
MENU
Hot Topic NBR Focus: GMO
Hot Topic NBR Focus: GMO
2 mins to read

Breathe Easy progresses to next phase of clinical trials

The cystic fibrosis drug developer raised $2 million earlier this year from angels and crowdfunding - with special audio feature.

Calida Smylie
Wed, 09 Dec 2015

Click the NBR Radio box for on-demand special feature audio: Breathe Easy chief executive Andrea Miller on the company's second phase of clinical trials

Biotech company Breathe Easy is launching its second phase of clinical trials for its cystic fibrosis drug, after raising $2 million earlier this

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

NZ$399.00 / yearly

Offer ends July 31st

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Calida Smylie
Wed, 09 Dec 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Breathe Easy progresses to next phase of clinical trials
54175
true